Biomarker for predicting tumor drug sensitivity and related product thereof
A biomarker and sensitivity technology, applied in the field of biomedicine, can solve difficult-to-predict problems and achieve high accuracy and good clinical application prospects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0067] Example 1 Screening of genes related to the sensitivity of metastatic melanoma to immune drug MAGE-A3
[0068] 1. Data sources and screening methods
[0069] Patients with clinically diagnosed metastatic melanoma were collected, and none of these patients had received immunotherapy with MAGE-A3 before immunotherapy with MAGE-A3. Before the patients with metastatic melanoma collected above received the immune drug MAGE-A3 immunotherapy, the tumor biopsy tissues of the patients were collected, and the response group (R, responder) or non-response group ( Differentially expressed genes in tumor tissues of NR, non-responder) patients. The MAGE-A3 immunotherapy refers to administering the immune drug MAGE-A3 to patients with metastatic melanoma, and the immune drug MAGE-A3 refers to a substance obtained by dissolving recombinant MAGE-A3 protein in an immunostimulator (AS02B or AS15) . Among them, according to whether the metastatic melanoma is responsive / sensitive to the ...
Embodiment 2
[0073] Application of Differentially Expressed Genes Screened in Example 2 in Predicting Sensitivity of Melanoma to Immunotherapy Drug MAGE-A3
[0074] 1. Experimental method
[0075] For the genes differentially expressed between the responder group and the non-response group screened in Example 1, receiver operating characteristic (ROC) analysis was performed using the R package "pROC" (version 1.15.0), and the receiver operating characteristic (ROC) was calculated. The area under the characteristic curve (AUC) is used to evaluate the accuracy of a single differentially expressed gene, any combination of two differentially expressed genes, and the combination of three differentially expressed genes for predicting the sensitivity of melanoma to the immune drug MAGE-A3 treatment, wherein the The range of AUC value is 0-1;
[0076] Among them, when judging the diagnostic efficacy of a single differentially expressed gene for predicting the sensitivity of melanoma to the immuno...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com